{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:59:47Z","timestamp":1791255587209,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T00:00:00Z","timestamp":1251936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T00:00:00Z","timestamp":1251936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/gt.2009.119","type":"journal-article","created":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T10:21:38Z","timestamp":1251973298000},"page":"141-146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6"],"prefix":"10.1038","volume":"17","author":[{"given":"C","family":"Towne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B L","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kieran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"D E","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Aebischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,3]]},"reference":[{"key":"BFgt2009119_CR1","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1172\/JCI22922","volume":"114","author":"M Azzouz","year":"2004","unstructured":"Azzouz M, Le T, Ralph GS, Walmsley L, Monani UR, Lee DC et al. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J Clin Invest 2004; 114: 1726\u20131731.","journal-title":"J Clin Invest"},{"key":"BFgt2009119_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm1205","volume":"11","author":"GS Ralph","year":"2005","unstructured":"Ralph GS, Radcliffe PA, Day DM, Carthy JM, Leroux MA, Lee DC et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 2005; 11: 429\u2013433.","journal-title":"Nat Med"},{"key":"BFgt2009119_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0304-3940(02)00454-8","volume":"328","author":"S Yamashita","year":"2002","unstructured":"Yamashita S, Mita S, Kato S, Okado H, Ohama E, Uchino M . Effect on motor neuron survival in mutant SOD1 (G93A) transgenic mice by Bcl-2 expression using retrograde axonal transport of adenoviral vectors. Neurosci Lett 2002; 328: 289\u2013293.","journal-title":"Neurosci Lett"},{"key":"BFgt2009119_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.1086137","volume":"301","author":"BK Kaspar","year":"2003","unstructured":"Kaspar BK, Llad\u00f3 J, Sherkat N, Rothstein JD, Gage FH . Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003; 301: 839\u2013842.","journal-title":"Science"},{"key":"BFgt2009119_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/ana.20453","volume":"57","author":"TM Miller","year":"2005","unstructured":"Miller TM, Kaspar BK, Kops GJ, Yamanaka K, Christian LJ, Gage FH et al. Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis. Ann Neurol 2005; 57: 773\u2013776.","journal-title":"Ann Neurol"},{"key":"BFgt2009119_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ymthe.2005.11.009","volume":"13","author":"RJ Mandel","year":"2006","unstructured":"Mandel RJ, Manfredsson FP, Foust KD, Rising A, Reimsnider S, Nash K et al. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Mol Ther 2006; 13: 463\u2013483.","journal-title":"Mol Ther"},{"key":"BFgt2009119_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/CMR.00008-08","volume":"21","author":"S Daya","year":"2008","unstructured":"Daya S, Berns KI . Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 2008; 21: 583\u2013593.","journal-title":"Clin Microbiol Rev"},{"key":"BFgt2009119_CR8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/mt.2008.73","volume":"16","author":"C Towne","year":"2008","unstructured":"Towne C, Raoul C, Schneider BL, Aebischer P . Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol Ther 2008; 16: 1018\u20131025.","journal-title":"Mol Ther"},{"key":"BFgt2009119_CR9","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.1128\/JVI.01288-06","volume":"80","author":"Z Wu","year":"2006","unstructured":"Wu Z, Asokan A, Grieger JC, Govindasamy L, Agbandje-McKenna M, Samulski RJ . Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. J Virol 2006; 80: 11393\u201311397.","journal-title":"J Virol"},{"key":"BFgt2009119_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/mt.2008.87","volume":"16","author":"A Toromanoff","year":"2008","unstructured":"Toromanoff A, Ch\u00e9rel Y, Guilbaud M, Penaud-Budloo M, Snyder RO, Haskins ME et al. Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle. Mol Ther 2008; 16: 1291\u20131299.","journal-title":"Mol Ther"},{"key":"BFgt2009119_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1172\/JCI26210","volume":"116","author":"M Pirozzi","year":"2006","unstructured":"Pirozzi M, Quattrini A, Andolfi G, Dina G, Malaguti MC, Auricchio A et al. Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia. J Clin Invest 2006; 116: 202\u2013208.","journal-title":"J Clin Invest"},{"key":"BFgt2009119_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/sj.mt.6300367","volume":"16","author":"ER Hollis II","year":"2008","unstructured":"Hollis II ER, Kadoya K, Hirsch M, Samulski RJ, Tuszynski MH . Efficient retrograde neuronal transduction utilizing self-complementary AAV1. Mol Ther 2008; 16: 296\u2013301.","journal-title":"Mol Ther"},{"key":"BFgt2009119_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/sj.mt.6300331","volume":"16","author":"RL Klein","year":"2008","unstructured":"Klein RL, Dayton RD, Tatom JB, Henderson KM, Henning PP . AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method. Mol Ther 2008; 16: 89\u201396.","journal-title":"Mol Ther"},{"key":"BFgt2009119_CR14","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/sj.mt.6300161","volume":"15","author":"Z Wang","year":"2007","unstructured":"Wang Z, Kuhr CS, Allen JM, Blankinship M, Gregorevic P, Chamberlain JS et al. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Mol Ther 2007; 15: 1160\u20131166.","journal-title":"Mol Ther"},{"key":"BFgt2009119_CR15","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/sj.gt.3302984","volume":"14","author":"K Yuasa","year":"2007","unstructured":"Yuasa K, Yoshimura M, Urasawa N, Ohshima S, Howell JM, Nakamura A et al. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Gene Therapy 2007; 14: 1249\u20131260.","journal-title":"Gene Therapy"},{"key":"BFgt2009119_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/mt.2008.225","volume":"17","author":"S Ohshima","year":"2009","unstructured":"Ohshima S, Shin JH, Yuasa K, Nishiyama A, Kira J, Okada T et al. Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle. Mol Ther 2009; 17: 73\u201380.","journal-title":"Mol Ther"},{"key":"BFgt2009119_CR17","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1128\/JVI.74.5.2420-2425.2000","volume":"74","author":"N Chirmule","year":"2000","unstructured":"Chirmule N, Xiao W, Truneh A, Schnell MA, Hughes JV, Zoltick P et al. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol 2000; 74: 2420\u20132425.","journal-title":"J Virol"},{"key":"BFgt2009119_CR18","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1128\/JVI.78.12.6344-6359.2004","volume":"78","author":"CS Peden","year":"2004","unstructured":"Peden CS, Burger C, Muzyczka N, Mandel RJ . Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. J Virol 2004; 78: 6344\u20136359.","journal-title":"J Virol"},{"key":"BFgt2009119_CR19","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/sj.mt.6300227","volume":"15","author":"S Reimsnider","year":"2007","unstructured":"Reimsnider S, Manfredsson FP, Muzyczka N, Mandel RJ . Time course of transgene expression after intrastriatal pseudotyped rAAV2\/1, rAAV2\/2, rAAV2\/5, and rAAV2\/8 transduction in the rat. Mol Ther 2007; 15: 1504\u20131511.","journal-title":"Mol Ther"},{"key":"BFgt2009119_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/hum.2008.151","volume":"20","author":"P Hadaczek","year":"2009","unstructured":"Hadaczek P, Forsayeth J, Mirek H, Munson K, Bringas J, Pivirotto P et al. Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Hum Gene Ther 2009; 20: 225\u2013237.","journal-title":"Hum Gene Ther"},{"key":"BFgt2009119_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/156652307782151498","volume":"7","author":"PR Lowenstein","year":"2007","unstructured":"Lowenstein PR, Mandel RJ, Xiong WD, Kroeger K, Castro MG . Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions. Curr Gene Ther 2007; 7: 347\u2013360.","journal-title":"Curr Gene Ther"},{"key":"BFgt2009119_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","volume":"12","author":"CS Manno","year":"2006","unstructured":"Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006; 12: 342\u2013347.","journal-title":"Nat Med"},{"key":"BFgt2009119_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jmg.15.6.409","volume":"15","author":"J Pearn","year":"1978","unstructured":"Pearn J . Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 1978; 15: 409\u2013413.","journal-title":"J Med Genet"},{"key":"BFgt2009119_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S1525-0016(03)00095-9","volume":"7","author":"D Grimm","year":"2003","unstructured":"Grimm D, Kay MA, Kleinschmidt JA . Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther 2003; 7: 839\u2013850.","journal-title":"Mol Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2009119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2009119","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2009119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T08:42:31Z","timestamp":1648543351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2009119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,3]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFgt2009119"],"URL":"https:\/\/doi.org\/10.1038\/gt.2009.119","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,3]]},"assertion":[{"value":"27 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}